Marquee Middle Image

Einstein in the News

The Sunday Times (UK) interviews Kelvin Davies, Ph.D., on his involvement in a study that used an innovative new drug-delivery system—nanoparticles infused with nitric oxide and applied topically---to successfully treat erectile dysfunction in animals. The nanoparticle technology was developed by Joel M. Friedman, M.D., Ph.D., professor of physiology & biophysics and of medicine at Einstein and his son, Adam Friedman, M.D., a resident in dermatology in Einstein’s department of medicine. The findings received extensive press coverage at the annual meeting of the American Urological Association on April 26, 2009. The topical treatment may offer localized therapeutic results with the benefit of a lower dosage and the avoidance of adverse side effects due to systemic absorption. Dr. Davies is associate professor of urology at Einstein.


More coverage on this story

Corriere (Italy)
Asian News International

Media coverage on other stories